Industry

BELLEVUE, Wash.–(BUSINESS WIRE)–$NVOS #AAPI–Novo Integrated Sciences, Inc. (NASDAQ: NVOS) (the “Company” or “Novo”), pioneering a holistic approach to patient-first health and wellness through a multidisciplinary healthcare ecosystem of multiple patient and consumer touchpoints for services and product innovation, today announced that Rob Mattacchione, CEO and Board Chairman, has been invited by the American Association of … [Read more…]

Ginger becomes first on-demand mental health platform with coaching, therapy and psychiatry services to have an Approved Health and Wellness Coach Training and Education Program by the NBHWC SANTA MONICA, Calif.–(BUSINESS WIRE)–Ginger, the leader in on-demand mental healthcare, today announced that The Ginger Training Institute Behavioral Health Coach Training Program has been designated an Approved … [Read more…]

AUSTIN, Texas–(BUSINESS WIRE)–Astrotech Corporation’s (NASDAQ: ASTC) subsidiary, BreathTech Corporation, announced today that it has amended its Joint Development and Option Agreement with Cleveland Clinic to include additional areas of focus. Under the amended agreement, ongoing work around development of a rapid breath test for COVID-19 will be expanded to utilize BreathTech’s core mass spectrometry technology … [Read more…]

BOSTON–(BUSINESS WIRE)–Kins, a digital-first, hybrid care physical therapy practice, announced today $4 million in new seed funding, raising $7.2M to-date, as well as expansion into Massachusetts. Kins’ recent funding round was led by W Health Ventures, which invests in and scales early-stage healthcare companies that are reinventing care delivery. Other notable angels in the medical … [Read more…]

Retail Comparable Store Prescriptions Increased 0.9 Percent – Comparable Store Non-COVID Acute Prescriptions Increased 11.9 Percent Revenues of $6.01 billion, Compared to Prior Year Revenues of $6.16 billion Net Loss per Share of $2.03, Compared to Prior Year Net Loss per Share of $0.24 Adjusted Net Loss per Share of $0.60, Compared to Prior Year … [Read more…]

NEW YORK–(BUSINESS WIRE)–Click Therapeutics, Inc. (“Click”), a leader in Digital Therapeutics™ as prescription medical treatments, today announced that Randall Stanicky, Chief Financial Officer, will present at the H.C. Wainwright 1st Annual Mental Health Conference on Monday, June 27, 2022 at 11:00 a.m. ET. The conference will be held in-person at the Lotte New York Palace … [Read more…]

DUBLIN–(BUSINESS WIRE)–The “Respiratory Syncytial Virus Fusion Protein Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players” report has been added to ResearchAndMarkets.com’s offering. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The … [Read more…]

CAMBRIDGE, Mass. & SALISBURY, England–(BUSINESS WIRE)–$KALV–KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of oral, small molecule protease inhibitors, today announced the acceptance of multiple abstracts at the 2022 European Academy of Allergy and Clinical Immunology (EAACI) Congress, taking place in Prague, Czech Republic and virtually, … [Read more…]

LifeWorks Mental Health Index™ reveals 20 percent of Americans are unable to meet basic needs due to inflation CHICAGO–(BUSINESS WIRE)–LifeWorks, a leading provider of digital and in-person total wellbeing solutions, today released its monthly Mental Health Index™ showing that the 20 percent of Americans who are not able to meet basic needs, such as food … [Read more…]

Company will pursue untapped opportunities in the field of innate immune system checkpoints to eliminate cancer Proprietary platform leverages CRISPR screening and macrophage biology to systematically discover and drug “don’t eat me” (DEM) and “eat me” (EM) signals CAMBRIDGE, Mass.–(BUSINESS WIRE)–DEM BioPharma, Inc. (DEM Bio), an immuno-oncology company developing therapies that target novel innate immune … [Read more…]